Treatment of Movement DisordersRoger Kurlan |
Other editions - View all
Common terms and phrases
abnormal action activity acute addition adult agents agonists Ann Neurol anticholinergics appear Arch Neurol associated behavior benefit botulinum toxin brain cause cells changes chorea chronic Clin clinical clonidine common controlled copper daily decreased deprenyl described diagnosis disabling dopamine dopaminergic dosage dose drug dyskinesia dystonia early epilepsy essential et al experience factors function haloperidol improvement increased induced initial injections involved jerks lesions less levels levodopa mechanism medication ment months motor movement disorders muscles myoclonus nerve Neurol neuroleptic Neurology normal observed occur onset Parkinson's disease patients period placebo present produce progressive Psychiatry received receptor reduced reported response risk seen seizures severe side effects spasms spinal stimulation symptomatic symptoms syndrome TABLE tardive therapy tics tion transplantation treated treatment tremor trial usually weeks Wilson's disease York